Buy Akorn (AKRX) on Sell-Off, Guggenheim Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Akorn (AKRX) Appoints Two New EVPs, One Corp. Controller
April 27, 2015 8:30 AM EDTAkorn (NASDAQ: AKRX) announced the following recent executive appointments for roles on the Akorn management team:
Jonathan Kafer, former Vice President, Account Management at Allergan, Inc., was appointed Executive Vice President, Sales and Marketing. In this newly-created role, Mr. Kafer will oversee all commercial functions for all of Akorn's business units. Mr. Kafer will also play an integral role in strategic market and product portfolio considerations. At Allergan, Mr. Kafer was responsible for all trade activity within Allergan's wholesale, retail specialty pharmacy, e-Solutions and managed market channels for... MorePiper Jaffray Downgrades Akorn (AKRX) to Neutral
April 27, 2015 6:53 AM EDTPiper Jaffray downgraded Akorn (NASDAQ: AKRX) from Overweight to Neutral with a price target of $53.00 (from $66.00) saying another restatement adds to credibility issues.
David Amsellem commented, "Akorn announced that it will need to further restate financials for 2014. The latest developments are particularly... More
Akorn (AKRX) Names Terry Rappuhn to Board
April 24, 2015 4:15 PM EDTAkorn, Inc. (Nasdaq: AKRX) today announced the appointment of Terry Allison Rappuhn to its Board of Directors and the Board's Audit Committee, effective immediately. In her accomplished career spanning over three decades working with and for public corporations, Ms. Rappuhn has helped rapidly growing companies build infrastructure, processes and teams during periods of transition.
"Terry is a terrific addition to our Board of Directors, and we... More
